Xiao et al.’s study indicates that CAFs increase the expression of the glutamine transporter SLC1A5 and significantly enhance the synthesis of nitrogen-containing compounds to fuel tumor cells (Li et al., 2021b), supporting our findings. The gene discussed is SLC1A5; the disease is neoplasm.